PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29768881-6	2018	In MTT test distearoyl floxuridine SLN showed a greater efficacy than floxuridine on all cancer cell lines revealing an efficiency about 100 times higher.	Floxuridine	23-34	sarcolipin	Homo sapiens	35-38	
29768881-7	2018	Also clonogenic assay showed a higher cytotoxicity of distearoyl-floxuridine-SLN compared to floxuridine but the difference between the formulations was only about 10 times.	Floxuridine	65-76	sarcolipin	Homo sapiens	77-80	
29768881-8	2018	In conclusion, SLN proved to be a promising vehicle to increase the floxuridine efficacy in cancer therapy.	Floxuridine	68-79	sarcolipin	Homo sapiens	15-18